Alok V. Joglekar, M.S., Ph.D.

Affiliations: 
California Institute of Technology, Pasadena, CA 
Area:
Gene Therapy
Google:
"Alok Joglekar"

Parents

Sign in to add mentor
Donald B. Kohn grad student 2009-2013 UCLA
 (Zinc Finger Nucleases for Site-Specific Correction of Adenosine Deaminase Deficiency.)
David Baltimore post-doc 2013- Caltech
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cillo AR, Somasundaram A, Shan F, et al. (2021) Critically ill COVID-19 patients exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 viral burden in the lung. Cell Reports. Medicine. 100476
Cillo AR, Somasundaram A, Shan F, et al. (2021) Bifurcated monocyte states are predictive of mortality in severe COVID-19. Biorxiv : the Preprint Server For Biology
Frankiw L, Mann M, Li G, et al. (2019) Alternative Splicing Coupled with Transcript Degradation Modulates OAS1g Antiviral Activity. Rna (New York, N.Y.)
Li G, Bethune MT, Wong S, et al. (2019) T cell antigen discovery via trogocytosis. Nature Methods. 16: 183-190
Joglekar AV, Leonard MT, Jeppson JD, et al. (2019) T cell antigen discovery via signaling and antigen-presenting bifunctional receptors. Nature Methods. 16: 191-198
Kuo CY, Long JD, Campo-Fernandez B, et al. (2018) Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome. Cell Reports. 23: 2606-2616
Joglekar AV, Liu Z, Weber JK, et al. (2018) T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable. Proceedings of the National Academy of Sciences of the United States of America
Hoban MD, Cost GJ, Mendel MC, et al. (2015) Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells. Blood. 125: 2597-604
Kuo CY, Hoban MD, Joglekar AV, et al. (2015) 121. Targeted Gene Therapy in the Treatment of X-Linked Hyper IgM Syndrome Molecular Therapy. 23: S50
Hoban MD, Mendel MC, Romero Z, et al. (2015) 115. Correction of the Sickle-Cell Disease Mutation in Human Hematopoietic Stem/Progenitor Cells Molecular Therapy. 23
See more...